Patient characteristics
| Patient | Sex | Age (yr) | Tumor Type | Tumor Location | DSA Grade, Reader 1/2 | CT–DSA Grade, Reader 1/2 | Estimated Tumor Volume (cm3) | Enhancement Index | Surgical Approach/Procedure | Preoperative Embolization | Blood Loss (cm3) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | M | 67 | Melanoma | L3 | 1/1 | 1/1 | 78.83 | 0.1574 | Posterior/debulking | Yes | 2300 |
| 2 | M | 55 | Colon cancer | L4 | 3/3 | 3/3 | 49.59 | 0.1659 | Posterior/debulking | Yes | 3950 |
| 3 | F | 44 | Renal cell carcinoma | C4 | 4/4 | 3/4 | 16.28 | 0.6254 | Anterior/debulking | Yes | 600 |
| 4 | M | 72 | Thyroid cancer | C7 | 2/1 | 2/3 | 11.93 | 0.1522 | Anterior/debulking | Yes | 800 |
| 5 | M | 54 | Breast cancer | L4 | 3/3 | 4/4 | 36.74 | 0.2586 | Posterior/debulking | Yes | 10,000 |
| 6 | M | 69 | Hepatocellular carcinoma | T10 | 4/4 | 3/4 | 18.14 | 0.2917 | Posterior/debulking | Yes | 4600 |
| 7 | F | 69 | Lung cancer | T4 | 1/0 | 1/1 | 10.86 | 0.1653 | Posterior/debulking | Yes | 3000 |
| 8 | M | 74 | Hepatocellular carcinoma | T10 | 2/3 | 1/1 | 22.25 | 0.0673 | Posterior/debulking | No | 1000 |
| 9 | F | 58 | Cervical cancer | L4–5 | 2/4 | 2/2 | 91.14 | 0.0734 | Posterior/debulking | Yes | 1400 |
| 10 | F | 51 | Lung cancer | L4–5 | 4/3 | 3/3 | 11.61 | 0.2183 | Posterior/debulking | Yes | 3400 |
| 11 | M | 60 | Hepatocellular carcinoma | T4 | 4/4 | 4/4 | 14.19 | 0.3325 | Posterior/debulking | Yes | 1400 |
| 12 | M | 64 | Hepatocellular carcinoma | T3 | 4/4 | 4/3 | 26.47 | 0.1888 | Posterior/debulking | Yes | 2000 |
| 13 | F | 64 | Breast cancer | T3–4 | 2/2 | 3/2 | 29.06 | 0.1107 | Posterior/debulking | Yes | 600 |
| 14 | F | 44 | Breast cancer | L5 | 0/1 | 2/2 | 42.86 | 0.0450 | Posterior/debulking | Yes | 200 |
| 15 | F | 58 | Parotid epithelial- myoepithelial carcinoma | T4 | 1/2 | 2/2 | 4.05 | 0.0339 | Posterior/en bloc | No | 2700 |